MOF-mediated acetylation of SIRT6 at K128, K160, and K267 reduces its deacetylase activity, impairs its interaction with FOXA2, activates ZEB2 transcription, and promotes NSCLC progression [41]. The gene discussed is SIRT6; the disease is non-small cell lung carcinoma.